Main menu

Pages

Huma Appoints Kaushik Gune Head of U.S. Healthcare Business to Drive Adoption of Digital Health Solutions

featured image

New YorkWhen London, August 11, 2022 /PR Newswire/ — Human Therapeutics Limitedis the world’s leading digital health company, Kaushik Gune as the company’s new head of U.S. healthcare. gune participate Huma The company’s digital health platform in the U.S., particularly its “home care” A platform for remote patient monitoring.


“Huma is transforming healthcare and research through its digital-first patient care platform, expanding access to patients, empowering clinical staff, and delivering data insights to researchers and providers.” said Gune. “I am proud to join the team working to transform healthcare for all.”

“Huma has established a strong track record of working with over 27 million patients across its platforms in the UK and around the world. Europe – both in primary and secondary care,” said Michael McDonnellSVP Healthcare and Head of Global Operations, Human Therapeutics“In the context of our digital health partnership with Huma, AstraZenecaand the coveted pre-galien Award-winning, we are now on a mission to deliver digital-first care and research to the U.S. market. Kaushik combines the business know-how and strategic insight necessary to bring our remote monitoring technology to millions of Americans, making him the perfect leader for our expansion. ”

During his career, Gune has held numerous senior management positions with a focus on developing and promoting commercial products in the digital health market. Most recently, he was Vice President of Digital Health & New Ventures at Smith + Nephew. Previously, he served as Chief Strategy and Business Development Officer at Innovative Health Diagnostics, leading the diagnostic lab through key growth stages managing financial, strategic and business development functions.

From a career spanning a variety of business functions, Gune brings experience in operations for United Airlines, strategy and commercials for McKinsey & Co, and finance for NuVasive. He holds a bachelor’s degree in mechanical engineering from university. MumbaiMSc in Industrial Engineering Purdue University He holds an MBA in Strategy and Finance from INSEAD.

About Huma

Huma Therapeutics is a global digital health company headquartered in the UK, advancing digital-first care delivery and research to help people live longer, fuller lives. His award-winning Huma modular platform is used in over 3,000 hospitals and clinics and has 1.8 million active his users. Huma’s offerings work across a variety of disease areas and forces.

– “home hospital”
– Software as a medical device (SaMD) solution
– DCT platform supporting digital or hybrid research

Huma’s platform will nearly double clinical capacity, reduce readmissions by more than a third, improve diversity, participant retention and protocol adherence, and enable trials to be conducted within weeks is shown.Please come www.huma.com Follow us on LinkedIn. Huma

Logo – https://mma.prnewswire.com/media/1427908/Huma_Logo.jpg

SOURCE Huma

.